RXI Pharma Revenue, Profits - RXII Annual Income Statement

Add to My Stocks
$1.24 $0.06 (5.08%) RXII stock closing price Sep 19, 2018 (Closing)

Financial analysis of RXI Pharma involves more than just checking the RXI Pharma stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement for RXII which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the RXI Pharma profit and loss statement for 2017 total to $14.07M. This line item shows that the operating expenses has increased compared with last year. Also check: RXI Pharma assets and RXI Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
RXI Pharma Revenues or Net Sales
-------
Cost Of Goods Sold (COGS)-------
RXI Pharma Gross Profit
-------
Research & Development Expense10.06M5.41M6.92M5.68M17.65M10.45M6.62M
Selling General & Admin Expense4.01M3.61M3.34M3.21M3.69M2.62M6.14M
Income Before Depreciation Depletion Amortization-14.06M-9.01M-10.23M-8.82M-20.94M-12.97M-12.77M
Depreciation Depletion Amortization-------
Non Operating Income-0.01M-----2.55M
Interest Expense-------
RXI Pharma Pretax Income
-14.07M-8.99M-10.22M-8.8M-20.92M-12.88M-10.21M
Provision for Income Taxes-1.62M------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-12.45M-8.99M-10.22M-8.8M-20.92M-12.88M-10.21M
Extraordinary Items & Discontinued Operations-------
RXI Pharma Profit/ Loss (Net Income)
-12.45M-8.99M-10.22M-8.8M-20.92M-12.88M-10.21M
Average Shares used to compute Diluted EPS2.26M------
Average Shares used to compute Basic EPS2.26M------
Income Before Nonrecurring Items-9.46M-8.99M-10.43M3.5M-20.93M--
Income from Nonrecurring Items-2.99M---12.3M---
RXI Pharma Earnings Per Share Basic Net
-5.52-16.40-21.00-79.00-288.00--
RXI Pharma Earnings Per Share Diluted Net
-5.52-16.40-21.00-79.00-288.00--
EPS Diluted Before Nonrecurring Items-4.20-16.40-21.00-4.00-288.00--
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing RXI Pharma stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: RXI Pharma revenue chart implies that the company is growing. It has not been the case with RXI Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like RXI Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the RXII income statement, one can check the RXI Pharma historical stock prices to check how the price has moved with time.

RXI Pharma Income Statement - Key Financial Ratios